Stockscreener 앱 받기
112.14
0.14%
0.16
전일 마감가:
$111.98
열려 있는:
$111.98
하루 거래량:
2.10M
Relative Volume:
0.85
시가총액:
$14.56B
수익:
$692.26M
순이익/손실:
$-512.41M
주가수익비율:
-26.45
EPS:
-4.24
순현금흐름:
$-274.36M
1주 성능:
+1.79%
1개월 성능:
+12.14%
6개월 성능:
+134.55%
1년 성능:
+200.56%
1일 변동 폭
$110.09
$115.54
1주일 범위
$103.80
$115.54
52주 변동 폭
$34.88
$115.54
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
GH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
112.14 | 14.54B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
가든트헬스 Stock (GH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-09-25 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | 재개 | Wells Fargo | Overweight |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-28 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 개시 | Craig Hallum | Buy |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-04-28 | 재개 | BTIG Research | Buy |
| 2022-02-24 | 재확인 | Canaccord Genuity | Buy |
| 2022-02-24 | 재확인 | Citigroup | Buy |
| 2022-02-24 | 재확인 | Cowen | Outperform |
| 2022-02-24 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-24 | 재확인 | SVB Leerink | Outperform |
| 2022-02-24 | 재확인 | Stifel | Buy |
| 2022-02-24 | 재확인 | Wells Fargo | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-11 | 개시 | Stifel | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-06-12 | 개시 | BTIG Research | Buy |
| 2020-02-21 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-08-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-16 | 개시 | Canaccord Genuity | Buy |
| 2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 재확인 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | JP Morgan | Overweight |
| 2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth - Seeking Alpha
Guardant Health stock hits 52-week high at 113.98 USD By Investing.com - Investing.com Nigeria
IPO Launch: How does Guardant Health Inc compare to its peersJuly 2025 Reactions & Daily Profit Maximizing Tips - baoquankhu1.vn
Guardant Health stock hits 52-week high at 113.98 USD - Investing.com India
Sumitomo Mitsui Trust Group Inc. Has $47.12 Million Position in Guardant Health, Inc. $GH - MarketBeat
Global Pan-Genomic and Multi-Gene Panel Testing Market Forecast to Hit US$ 25.91 Billion by 2032 at 12.04% CAGR, Driven by Growing Demand for Comprehensive Multi-Gene Diagnostics: AnalystView Market Insights - GlobeNewswire Inc.
BLOODPAC Publishes New Standards for Liquid Biopsy Tests That Monitor for Cancer Recurrence - PA Media
Guardant Health (NASDAQ:GH): Strongest Q3 Results from the Testing & Diagnostics Services Group - Yahoo Finance
Guardant Health Announces Strong 2025 Preliminary Revenue Growth - The Globe and Mail
Guardant Health guides Q4 and FY25 revenue above consensus - MSN
Guardant Health (NASDAQ:GH) Reaches New 12-Month HighStill a Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), SI-Bone (SIBN) and Guardant Health (GH) - The Globe and Mail
Guardant Health shares up 2.4% after preliminary Q4 revenue beats estimates - marketscreener.com
Guardant Health, Inc. (GH) Stock Analysis: Strong Buy Potential with 38.5% Revenue Growth and Robust Analyst Support - DirectorsTalk Interviews
Guardant Health rises after Q4 revenue surpasses estimate - TradingView — Track All Markets
Guardant Health, Inc. $GH Shares Sold by D.A. Davidson & CO. - MarketBeat
Guardant Health Sees 39% Rise in Q4 Preliminary Revenue - marketscreener.com
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results - BioSpace
Guardant Health (GH) Surpasses Revenue Estimates with Strong Onc - GuruFocus
Guardant Health prelim Q4 revenue rises 39%, beats expectations - TradingView — Track All Markets
Guardant Health Q4 total revenue of approx $280 million - marketscreener.com
Discipline and Rules-Based Execution in GH Response - Stock Traders Daily
Guggenheim Analyst is Bullish on Guardant Health, Inc. (GH) - Finviz
How Recent Analyst Targets Are Shaping The Evolving Story For Guardant Health (GH) - Yahoo Finance
Guardant Health (GH) Is Up 8.3% After TRICARE Adds No-Copay Shield Coverage For Service Members - Yahoo Finance
Is Guardant Health (GH) Share Surge Justified By Recent Valuation Signals? - Yahoo Finance
Guardant Health is the top performing healthcare services stock YTD - MSN
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families in Florida - Florida Hospital News and Healthcare Report
Stifel raises Guardant Health stock price target to $120 on growth outlook - Investing.com Canada
Guardant Health (GH): Stifel Raises Price Target to $120.00 | GH Stock News - GuruFocus
Insider Sell: Terilyn Monroe Sells Shares of Guardant Health Inc (GH) - GuruFocus
Insider Selling: Guardant Health (NASDAQ:GH) Insider Sells 10,031 Shares of Stock - MarketBeat
Clinical Labs Hope to Head Off Looming Medicare Cuts - Barron's
Aug Swings: How strong is Guardant Health Inc. stock balance sheetJuly 2025 Market Mood & Technical Buy Zone Confirmation - ulpravda.ru
How Guardant Health Inc. stock compares to industry benchmarks2025 EndofYear Setup & Expert Curated Trade Setups - ulpravda.ru
Can Guardant Health Inc. stock continue upward trendWeekly Investment Summary & Reliable Breakout Forecasts - ulpravda.ru
Guardant Health’s Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families - The Joplin Globe
Will Guardant Health Inc. stock deliver better than expected guidanceTrendline Breakouts & Rapid Wealth Accumulation - ulpravda.ru
Guardant Health, Inc.Common Stock (NQ: GH - FinancialContent
Assessing Guardant Health (GH) Valuation After Analyst Upgrades And New Cancer Test Partnerships - Yahoo Finance
Guardant Health stock hits 52-week high at 112.43 USD By Investing.com - Investing.com Nigeria
Guardant Health (NASDAQ:GH) Sets New 1-Year HighHere's Why - MarketBeat
Guardant Health stock hits 52-week high at 112.43 USD - Investing.com
Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next - TechStock²
GH Virtual Meeting Scheduled by BTIG for January 12 - GuruFocus
Guardant Health (NASDAQ:GH) Stock Rating Lowered by Evercore ISI - MarketBeat
Evercore ISI Group downgrades Guardant Health (GH) - MSN
GH: Evercore ISI Group Downgrades Guardant Health While Raising Price Target | GH Stock News - GuruFocus
GH: Guggenheim Raises Price Target for Guardant Health to $115 | - GuruFocus
VIRGINIA RETIREMENT SYSTEMS ET Al Takes Position in Guardant Health, Inc. $GH - MarketBeat
Allspring Global Investments Holdings LLC Makes New $39.52 Million Investment in Guardant Health, Inc. $GH - MarketBeat
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.51%
0.74%
자본화:
|
볼륨(24시간):